Rohto Pharmaceutical Co.,Ltd.
4527
Classement en actions
#3848
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global... Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
Prix de l'action
$19.13
Capitalisation boursière
$4.32B
Changement (1 jour)
0.64%
Changement (1 an)
16.90%
Pays
JP
Échange Rohto Pharmaceutical Co.,Ltd. (4527)
Catégorie
Consumer Defensive
Revenus pour Rohto Pharmaceutical Co.,Ltd. (4527)
Revenus en Jun 2026 TTM : $2.31B
Selon les derniers rapports financiers de Rohto Pharmaceutical Co.,Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de $2.31B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $1.79B une diminution par rapport à le chiffre d'affaires de l'année 2023, qui était de $1.80B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Rohto Pharmaceutical Co.,Ltd. de 2008 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $2.31B | 11.98% |
| 2025 | $2.06B | 15.06% |
| 2024 | $1.79B | -0.45% |
| 2023 | $1.80B | 9.63% |
| 2022 | $1.64B | 0.31% |
| 2021 | $1.63B | -6.70% |
| 2020 | $1.75B | 5.89% |
| 2019 | $1.65B | 2.34% |
| 2018 | $1.62B | 16.49% |
| 2017 | $1.39B | -6.19% |
| 2016 | $1.48B | 16.76% |
| 2015 | $1.27B | -9.28% |
| 2014 | $1.40B | 2.31% |
| 2013 | $1.37B | -5.93% |
| 2012 | $1.45B | 4.39% |
| 2011 | $1.39B | 14.55% |
| 2010 | $1.21B | 8.00% |
| 2009 | $1.12B | 3.58% |
| 2008 | $1.09B | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $87.03B | 3,674.79% |
US
|
|
| $51.67B | 2,140.87% |
FR
|
|
| $21.05B | 812.82% |
US
|
|
| $7.28B | 215.96% |
IN
|
|
| $15.05B | 552.71% |
US
|
